Antagen Pharmaceuticals Inc, based in Boston, MA, is a leading biopharmaceutical company focused on developing innovative solutions to address critical healthcare needs. With a strong emphasis on infection, cancer, and autoimmune diseases, AntagenPharma is committed to saving lives by rapidly advancing the development of biologics as countermeasures against Acute Respiratory Distress Syndrome caused by COVID-19.
Driven by cutting-edge technology and a team of dedicated scientists, AntagenPharma pioneers biologics development through its high-performance protein antibody mammalian cell expression platforms and glyco-engineered CHO cell expression technologies. Their mission is to combat infectious, cancerous, and autoimmune diseases through novel scientific approaches, with a particular focus on containing the COVID-19 epidemic.
Generated from the website